Skip to content
DiogenX logo

DiogenX Alternatives & Competitors

8 companies similar to DiogenX — Targeting Beta Cell recovery in Diabetes

Companies similar to DiogenX

Sidansai logo — alternative to DiogenX

Sidansai

A Shanghai-based biotechnology company pioneering the advancement of cell therapy.

Aurion Biotech logo — alternative to DiogenX

Aurion Biotech

We're on a mission to cure blindness with our transformational platform of advanced therap...

Histide logo — alternative to DiogenX

Histide

Histide uses non-mutagenic CRMs to stimulate a cell's natural capacity to redirect its own...

Bridge Medicines LLC logo — alternative to DiogenX

Bridge Medicines LLC

ACCELERATING THE PATH TO THE PATIENT

Rival Readout

Competing with DiogenX? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Microviable Therapeutics SL logo — alternative to DiogenX

Microviable Therapeutics SL

Developing novel biological drugs based on the microbiome to address unmet challenges in h...

Taiga Biotechnologies logo — alternative to DiogenX

Taiga Biotechnologies

Taiga Biotechnologies is a clinical stage biotechnology company focused on harnessing the...

Biomed Valley Discoveries logo — alternative to DiogenX

Biomed Valley Discoveries

Biotech, Purposefully Reimagined

Cellular Intelligence logo — alternative to DiogenX

Cellular Intelligence

Cellular Intelligence

About DiogenX

DiogenX, founded in 2020, is a preclinical-stage biotech company based in France, with headquarters in Marseille and labs in Nice. The company operates under the slogan "Targeting Beta Cell recovery in Diabetes," reflecting its commitment to developing innovative biologics aimed at offering new therapeutic options for...

Services

Discovery and Development of Biologics, Regenerative Treatment for Type 1 Diabetes

Target Customers

Diabetic Patients, Healthcare Professionals, Research and Development Organizations

Business keywords

Biotech, Preclinical Stage, Beta-cell Recovery, Diabetes Therapeutics, Type 1 Diabetes, Type 2 Diabetes, Insulin-producing Cells, Pancreatic Beta-cell Modulators, Insulin Homeostasis, Novel Biologics, Collaborative Research, Clinical Innovation, Regenerative Medicine, Beta-cell Regeneration, Therapeutic Development

Business Model

B2B, White Label

Revenue Model

Licensing, Product Sales, Value Based Pricing

Frequently Asked Questions

Companies similar to DiogenX include Sidansai, Aurion Biotech, Histide, Bridge Medicines LLC, Microviable Therapeutics SL. They share DiogenX's focus on biotech, regenerative medicine and collaborative research.
Bounce Watch lists 8 companies that share DiogenX's industries and are closest to it in business tags, services, target customers, business model and size.
DiogenX, founded in 2020, is a preclinical-stage biotech company based in France, with headquarters in Marseille and labs in Nice. The company operates under the slogan "Targeting Beta Cell recovery in Diabetes," reflecting its commitment to developing innovative biologics aimed at offering new therapeutic options for...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around DiogenX: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at DiogenX on 11 May 2026. The 8 companies listed here were last checked between 11 Sep 2024 and 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout